# Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia

> **NCT04527354** · PHASE2 · COMPLETED · sponsor: **PHARMENTERPRISES LLC** · enrollment: 60 (actual)

## Conditions studied

- SARS-CoV-2 Infection
- Fibrosis Lung

## Interventions

- **DRUG:** Treamid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04527354
- **Lead sponsor:** PHARMENTERPRISES LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2021-02-10
- **Final completion:** 2021-02-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04527354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04527354, "Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04527354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*